Search For "shalini"
Study on feasibility of mixing COVID-19 vaccine doses to be available by F
Updated : 4 years, 5 months ago IST
New Delhi [India], December 31 (ANI): The effectiveness of heterologous vaccine doses against new COVID-19 variants is likely to come in six weeks after the trial in the Christian Medical College, Vellore, said top virologist, Dr Gagandeep Kang, on Friday.
Read More
Children should be sent to schools, COVID-19 infection generally not sever
Updated : 4 years, 5 months ago IST
New Delhi [India], December 31 (ANI): With India set to begin vaccination of children in the 15-18 age group from January 3 against coronavirus, Dr Gagandeep Kang, a leading virologist, has said that children should go to schools as COVID-19 infection is not much severe in them.
Read More
We have to learn to live with COVID-19, India better prepared to deal with
Updated : 4 years, 5 months ago IST
New Delhi [India], Dec 31 (ANI): Noting that people will have to learn to live with COVID-19 due to the possibility of the emergence of new virus variants, India's leading virologist Dr Gagandeep Kang has said that the country is better prepared to deal with coronavirus amid a rise in cas
Read More
Dr. Gagandeep Kang suggests people to learn to live with SARS-CoV-2 as its
Updated : 4 years, 5 months ago IST
New Delhi [India], December 31 (ANI): Suggesting people to learn to live with SARS-CoV-2 and its variants which will continue to emerge, Virologist Dr Gagandeep Kang, however, on Friday said that the Omicron variant of coronavirus is comparatively less severe than other variants.
Read More
Surge in COVID-19 cases in India as Omicron started replacing Delta varian
Updated : 4 years, 5 months ago IST
New Delhi [India], December 31 (ANI): With the Union Health Ministry noting a surge in COVID-19 cases across the country, official sources have said that the reason behind the spike is the Omicron variant which has started replacing its predecessor Delta in India and the world.
Read More
Durability of immunity post-COVID-19 infection persists for 9 months: DG I
Updated : 4 years, 5 months ago IST
New Delhi [India], December 30 (ANI): The durability of immunity after the COVID-19 infection persists for at least 9 months as per the evidence-based studies from different countries globally, said Dr. Balram Bhargava, Director General, Indian Council of Medical Research (ICMR) on Thursd
Read More
Omicron will spread like fire globally, produces protection against Delta:
Updated : 4 years, 5 months ago IST
New Delhi [India], December 30 (ANI): A top health expert has linked rising COVID-19 cases in India with the Omicron variant and said it will spread like a fire globally but would produce some protection even against the Delta variant.
Read More
Governor of Maharashtra awards 35 inspiring innovators and entrepreneurs f
Updated : 4 years, 5 months ago IST
New Delhi [India], December 30 (ANI/ATK): Governor of Maharashtra Bhagat Singh Koshyari presented the Annual Impact Creator Awards 2021, to 35 innovators and entrepreneurs during an award ceremony held at Raj Bhavan, Mumbai on December 18, 2021.
Read More
Don't panic, but be vigilant: AIIMS Director Dr Guleria amid Omicron scare
Updated : 4 years, 5 months ago IST
New Delhi [India], December 30 (ANI): In view of the rising Omicron cases across the country, All India Institute of Medical Sciences (AIIMS) Delhi Director Dr Randeep Guleria on Wednesday advised people "not to panic, but to be vigilant" while extending New Year greetings.
Read More
Biological E gets approval to conduct trials of Corbevax as booster dose
Updated : 4 years, 5 months ago IST
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Read More
Prescription not required by senior citizens to establish co-morbidity for
Updated : 4 years, 5 months ago IST
New Delhi [India], December 28 (ANI): Senior citizens with co-morbidities will not be required to produce a doctor's certificate or prescription at the time of administration of precaution dose, Union Health Ministry said on Saturday.
Read More
Centre clears two new COVID vaccines, one antiviral drug; manufacturers we
Updated : 4 years, 5 months ago IST
New Delhi [India], December 28 (ANI): After the Union Health Ministry cleared two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, vaccine manufacturers welcomed the announcement and said that this would support the patients across India.
Read More